Novel β-Carboline Derivative ZLWH-67 Exerts Potent Anti-MRSA Activity through Multiple Mechanisms

Area of Science:

• Microbiology
• Pharmacology
• Drug Discovery

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant global health threat.
• There is an urgent need for novel antibacterial agents to combat rising antimicrobial resistance.

Purpose of the Study:

• To investigate the antibacterial activity and mechanisms of a new beta-carboline derivative, ZLWH-67, against MRSA.
• To evaluate the safety and efficacy of ZLWH-67 in preclinical models.

Main Methods:

• Antibacterial activity and cytotoxicity assays.
• In vivo efficacy studies in mouse infection models.
• RNA-sequencing (RNA-seq) and RT-PCR for mechanistic investigations.

Main Results:

• ZLWH-67 demonstrated potent bactericidal activity against MRSA with low cytotoxicity and hemolytic toxicity.
• The compound was safe in vivo and not susceptible to resistance development.
• Mechanistic studies revealed multiple modes of action including biofilm inhibition, membrane disruption, and DNA damage.

Conclusions:

• ZLWH-67 is a promising anti-MRSA candidate with a multi-targeted mechanism of action.
• Its efficacy in vivo comparable to vancomycin warrants further clinical investigation.